Soranix

Soranix is Sorafenib, an oral multi-kinase inhibitor. It is indicated for hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid cancer and works by blocking tumor proliferation and angiogenesis pathways.

Features